Sugi Predict

Sugi Predict / Compounds / SCHEMBL540293

SCHEMBL540293

SCHEMBL540293

C#Cc1ccc(B(O)O)cc1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ENPP2 Q13822 5/20 0.58
▸ CA2 P00918 5/20 0.46
▸ CA1 P00915 4/20 0.46
▸ LPL P06858 2/20 0.46
▸ LIPG Q9Y5X9 2/20 0.46
▸ TSHR P16473 1/20 0.46
▸ CA4 P22748 1/20 0.43
▸ CA6 P23280 1/20 0.43
▸ CA5A P35218 1/20 0.43
▸ CA7 P43166 1/20 0.43
▸ CA14 Q9ULX7 1/20 0.43
▸ CA5B Q9Y2D0 1/20 0.43
▸ MGLL Q99685 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ HDAC8 Q9BY41 1/20 0.40
▸ F11 P03951 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL806832 0.78 ENPP2 (0.64) ENPP2CA2CA1LPLLIPG
SCHEMBL806833 0.78 ENPP2 (0.64) ENPP2CA2CA1LPLLIPG
SCHEMBL204921 0.76 ENPP2 (0.73) ENPP2CA2CA1LPLLIPG
SCHEMBL28871 0.76 HDAC8 (0.59) CA2CA1CA4CA14HDAC8
SCHEMBL3718497 0.74 ENPP2 (0.58) ENPP2CA2CA1LPLLIPG
SCHEMBL806834 0.74 ENPP2 (0.58) ENPP2CA2CA1LPLLIPG
SCHEMBL6016 0.74 ENPP2 (1.00) ENPP2CA2CA1LPLLIPG
Ammonia Solution, Strong SCHEMBL22721248 0.73 HDAC8 (0.56) CA2CA1CA4CA14HDAC8
SCHEMBL10481152 0.73 HDAC8 (0.56) CA2CA1CA4CA14HDAC8
Bromide SCHEMBL27350147 0.73 HDAC8 (0.56) CA2CA1CA4CA14HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115959993-B Synthesis method of 2-aryl propionic acid compound 山东中医药大学 2025-01-07 — — CN claimed
CN-118616024-A Boron-affinity molecular imprinting covalent organic framework material and preparation and application thereof 江南大学 2024-09-10 — — CN claimed
CN-118599079-A Boric acid functionalized covalent organic framework material and preparation method and application thereof 武汉工程大学 2024-09-06 — — CN claimed
CN-117903167-A Terminal alkyne-substituted Raman molecule and preparation method and application thereof 武汉市博雅生物有限公司 2024-04-19 — — CN claimed
CN-115959993-A Synthetic method of 2-aryl propionic acid compound 山东中医药大学 2023-04-14 — — CN claimed
US-20260053393-A1 NEAR-IR GLUCOSE SENSORS PROFUSA INC (US) 2026-02-26 — — US disclosed
CN-120424358-A Boron-affinity covalent organic framework material with core-shell structure, preparation method and online application thereof 遵义医科大学 2025-08-05 — — CN disclosed
US-20250230174-A1 NEAR-IR GLUCOSE SENSORS PROFUSA, INC. (US) 2025-07-17 — — US disclosed
WO-2025129076-A1 PYRIDOPYRIMIDINE AND QUINAZOLINE DERIVATIVES AS USP1 INHIBITORS, COMPOSITIONS COMPRISING THEM AND METHODS OF USING THE SAME EIKON THERAPEUTICS, INC. (US) 2025-06-19 — — WO disclosed
CN-119980519-A Preparation method of low-cost in-situ doped continuous silicon carbide fiber 福建立亚新材有限公司 2025-05-13 — — CN disclosed
CN-119980518-A Preparation method of low-cost in-situ doped silicon nitride fiber 福建立亚新材有限公司 2025-05-13 — — CN disclosed
US-12285250-B2 Near-IR glucose sensors PROFUSA, INC (US) 2025-04-29 — — US disclosed
WO-2010117635-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2010-10-14 — — WO disclosed
WO-2010100475-A1 HYDROXAMIC ACID DERIVATIVES AS GRAM-NEGATIVE ANTIBACTERIAL AGENTS ASTRAZENECA AB (SE) 2010-09-10 — — WO disclosed
WO-2009126691-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC (US) 2009-10-15 — — WO disclosed
WO-2009126691-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC (US) 2009-10-15 — — WO disclosed
EP-1270582-B1 TRIPHENYLPHOSPHINE DERIVATIVES, PALLADIUM OR NICKEL COMPLEXES THEREOF, AND PROCESS FOR PREPARING BIARYL DERIVATIVES MITSUBISHI RAYON CO (JP) 2006-08-30 — — EP disclosed
US-6693210-B2 USING PALLADIUM, NICKEL PHOSPHINE COMPLEX AS CATALYSTS MITSUBISHI RAYON CO., LTD. (JP) 2004-02-17 — — US disclosed
US-20030065208-A1 Using palladium, nickel phosphine complex as catalysts MITSUBISHI RAYON CO., LTD. (JP) 2003-04-03 — — US disclosed
EP-1270582-A1 TRIPHENYLPHOSPHINE DERIVATIVE, PRODUCTION PROCESS THEREFOR, PALLADIUM COMPLEX THEREOF, AND PROCESS FOR PRODUCING BIARYL DERIVATIVE Mitsubishi Rayon Co., Ltd. (JP) 2003-01-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250230174-A1 NEAR-IR GLUCOSE SENSORS IRS1, INSR, SLC2A4 ENPP2 3924/4885CA2 935/4885CA1 2222/4885
US-20260053393-A1 NEAR-IR GLUCOSE SENSORS INSR, IRS1, SLC2A4 ENPP2 4732/4885CA2 122/4885CA1 547/4885
US-20030065208-A1 Using palladium, nickel phosphine complex as catalysts PDCD1LG2, PIK3CA, PDCD1 ENPP2 2041/4885CA2 2561/4885CA1 2588/4885
US-12285250-B2 Near-IR glucose sensors IRS1, SLC2A4, GPR119 ENPP2 4439/4885CA2 686/4885CA1 1403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.